Title:
【発明の名称】リウマチ性炎症性プロセスに対する5-HT3レセプターアンタゴニストの全身的使用
Document Type and Number:
Japanese Patent JP2002537255
Kind Code:
A
Abstract:
The present invention relates to a new use for compounds having 5-HT3 (serotonin M) receptor antagonist activity, especially tropisetron, for the manufacture of a pharmaceutical composition for the systemic treatment of an inflammatory rheumatic or rheumatoid disease other than crystal induced arthritis and other than living pathogen induced inflammatory diseases as long as the living pathogen is still present.
Inventors:
Roter Felber
Wolfgang Mueller
Thomas STRATZ
Wolfgang Mueller
Thomas STRATZ
Application Number:
JP2000599389A
Publication Date:
November 05, 2002
Filing Date:
February 16, 2000
Export Citation:
Assignee:
Novartis Actien Gezel Shaft
International Classes:
C07D233/64; A61K31/00; A61K31/417; A61K31/4178; A61K31/4184; A61K31/436; A61K31/437; A61K31/439; A61K45/00; A61K45/06; A61P19/00; A61P29/00; A61P43/00; C07D403/06; C07D451/12; C07D471/04; C07D471/08; (IPC1-7): A61K45/00; A61K31/4178; A61K31/4184; A61K31/436; A61K31/437; A61K31/439; A61P29/00; A61P43/00; C07D233/64; C07D451/12; C07D471/04; C07D471/08
Foreign References:
| WO1999001114A1 | 1999-01-14 |
Attorney, Agent or Firm:
Aoyama Ryo (2 outside people)